| UniProt ID | FXR1_HUMAN | |
|---|---|---|
| UniProt AC | P51114 | |
| Protein Name | Fragile X mental retardation syndrome-related protein 1 | |
| Gene Name | FXR1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 621 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | RNA-binding protein required for embryonic and postnatal development of muscle tissue. May regulate intracellular transport and local translation of certain mRNAs (By similarity).. | |
| Protein Sequence | MAELTVEVRGSNGAFYKGFIKDVHEDSLTVVFENNWQPERQVPFNEVRLPPPPDIKKEISEGDEVEVYSRANDQEPCGWWLAKVRMMKGEFYVIEYAACDATYNEIVTFERLRPVNQNKTVKKNTFFKCTVDVPEDLREACANENAHKDFKKAVGACRIFYHPETTQLMILSASEATVKRVNILSDMHLRSIRTKLMLMSRNEEATKHLECTKQLAAAFHEEFVVREDLMGLAIGTHGSNIQQARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNPYSLLDNTESDQTADTDASESHHSTNRRRRSRRRRTDEDAVLMDGMTESDTASVNENGLVTVADYISRAESQSRQRNLPRETLAKNKKEMAKDVIEEHGPSEKAINGPTSASGDDISKLQRTPGEEKINTLKEENTQEAAVLNGVS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAELTVEVR ------CCEEEEEEE | 22.10 | 22814378 | |
| 11 | Phosphorylation | LTVEVRGSNGAFYKG EEEEEECCCCCEEEC | 22.86 | 28348404 | |
| 17 | Acetylation | GSNGAFYKGFIKDVH CCCCCEEECEEEEEC | 40.67 | 26051181 | |
| 17 | Ubiquitination | GSNGAFYKGFIKDVH CCCCCEEECEEEEEC | 40.67 | - | |
| 56 | Sumoylation | LPPPPDIKKEISEGD CCCCCCCCCCCCCCC | 52.30 | 28112733 | |
| 56 | Ubiquitination | LPPPPDIKKEISEGD CCCCCCCCCCCCCCC | 52.30 | 21906983 | |
| 56 (in isoform 1) | Ubiquitination | - | 52.30 | 21906983 | |
| 56 (in isoform 2) | Ubiquitination | - | 52.30 | 21906983 | |
| 57 | Ubiquitination | PPPPDIKKEISEGDE CCCCCCCCCCCCCCE | 61.69 | - | |
| 60 | Phosphorylation | PDIKKEISEGDEVEV CCCCCCCCCCCEEEE | 36.30 | 28985074 | |
| 68 | Phosphorylation | EGDEVEVYSRANDQE CCCEEEEEECCCCCC | 4.48 | 25147952 | |
| 77 | Glutathionylation | RANDQEPCGWWLAKV CCCCCCCCHHEEEEE | 7.58 | 22555962 | |
| 83 | Acetylation | PCGWWLAKVRMMKGE CCHHEEEEEEHHCCC | 28.36 | 26051181 | |
| 83 | Ubiquitination | PCGWWLAKVRMMKGE CCHHEEEEEEHHCCC | 28.36 | 83 | |
| 83 (in isoform 1) | Ubiquitination | - | 28.36 | 21906983 | |
| 83 (in isoform 2) | Ubiquitination | - | 28.36 | 21906983 | |
| 92 | Phosphorylation | RMMKGEFYVIEYAAC EHHCCCEEEEEEEEE | 9.01 | 26552605 | |
| 96 | Phosphorylation | GEFYVIEYAACDATY CCEEEEEEEEECCCC | 6.59 | 26552605 | |
| 102 | Phosphorylation | EYAACDATYNEIVTF EEEEECCCCCEEEEE | 17.39 | 26552605 | |
| 103 | Phosphorylation | YAACDATYNEIVTFE EEEECCCCCEEEEEE | 16.72 | 26552605 | |
| 108 | Phosphorylation | ATYNEIVTFERLRPV CCCCEEEEEEEECCC | 25.99 | 26552605 | |
| 119 | Ubiquitination | LRPVNQNKTVKKNTF ECCCCCCCCCCCCCE | 44.95 | - | |
| 128 | Ubiquitination | VKKNTFFKCTVDVPE CCCCCEEEEEEECCH | 25.46 | - | |
| 148 | Ubiquitination | CANENAHKDFKKAVG HHCCCHHHHHHHHHH | 63.55 | - | |
| 161 (in isoform 3) | Ubiquitination | - | 17.69 | 21906983 | |
| 179 | Ubiquitination | SASEATVKRVNILSD ECCHHCHHHHHHCCH | 46.39 | - | |
| 188 (in isoform 3) | Ubiquitination | - | 24.07 | 21906983 | |
| 190 | Methylation | ILSDMHLRSIRTKLM HCCHHHHHHHHHHHH | 18.50 | - | |
| 191 | Phosphorylation | LSDMHLRSIRTKLML CCHHHHHHHHHHHHH | 23.84 | - | |
| 194 | Phosphorylation | MHLRSIRTKLMLMSR HHHHHHHHHHHHHHC | 27.19 | 26552605 | |
| 195 | Acetylation | HLRSIRTKLMLMSRN HHHHHHHHHHHHHCC | 23.27 | 25953088 | |
| 195 | Ubiquitination | HLRSIRTKLMLMSRN HHHHHHHHHHHHHCC | 23.27 | - | |
| 200 | Phosphorylation | RTKLMLMSRNEEATK HHHHHHHHCCHHHHH | 28.17 | 28851738 | |
| 206 | Phosphorylation | MSRNEEATKHLECTK HHCCHHHHHHHHHHH | 23.44 | 26552605 | |
| 207 | Acetylation | SRNEEATKHLECTKQ HCCHHHHHHHHHHHH | 53.92 | 25953088 | |
| 207 | Ubiquitination | SRNEEATKHLECTKQ HCCHHHHHHHHHHHH | 53.92 | - | |
| 213 | Ubiquitination | TKHLECTKQLAAAFH HHHHHHHHHHHHHHC | 55.78 | - | |
| 225 (in isoform 3) | Ubiquitination | - | 7.24 | 21906983 | |
| 236 | Phosphorylation | LMGLAIGTHGSNIQQ HHHHHCCCCCCCHHH | 19.56 | 20873877 | |
| 239 | Phosphorylation | LAIGTHGSNIQQARK HHCCCCCCCHHHHHC | 24.13 | 20873877 | |
| 240 (in isoform 3) | Ubiquitination | - | 40.45 | 21906983 | |
| 246 | Ubiquitination | SNIQQARKVPGVTAI CCHHHHHCCCCEEEE | 56.66 | 21906983 | |
| 246 (in isoform 1) | Ubiquitination | - | 56.66 | 21906983 | |
| 246 (in isoform 2) | Ubiquitination | - | 56.66 | 21906983 | |
| 265 | Phosphorylation | DTGTFRIYGESADAV CCCEEEEEECCHHHH | 15.58 | 28152594 | |
| 268 | Phosphorylation | TFRIYGESADAVKKA EEEEEECCHHHHHHH | 27.38 | 28152594 | |
| 273 | Ubiquitination | GESADAVKKARGFLE ECCHHHHHHHHHHHH | 42.30 | 21906983 | |
| 273 (in isoform 1) | Ubiquitination | - | 42.30 | 21906983 | |
| 273 (in isoform 2) | Ubiquitination | - | 42.30 | 21906983 | |
| 274 | Ubiquitination | ESADAVKKARGFLEF CCHHHHHHHHHHHHH | 36.40 | - | |
| 295 | Acetylation | VPRNLVGKVIGKNGK CCHHHHHHHHCCCCC | 24.17 | 25953088 | |
| 295 | Malonylation | VPRNLVGKVIGKNGK CCHHHHHHHHCCCCC | 24.17 | 26320211 | |
| 295 | Ubiquitination | VPRNLVGKVIGKNGK CCHHHHHHHHCCCCC | 24.17 | - | |
| 302 | Acetylation | KVIGKNGKVIQEIVD HHHCCCCCEEEEEEC | 45.63 | 25953088 | |
| 302 | Ubiquitination | KVIGKNGKVIQEIVD HHHCCCCCEEEEEEC | 45.63 | - | |
| 310 | Acetylation | VIQEIVDKSGVVRVR EEEEEECCCCCEEEE | 37.91 | 26051181 | |
| 310 | Ubiquitination | VIQEIVDKSGVVRVR EEEEEECCCCCEEEE | 37.91 | 21906983 | |
| 310 (in isoform 1) | Ubiquitination | - | 37.91 | 21906983 | |
| 310 (in isoform 2) | Ubiquitination | - | 37.91 | 21906983 | |
| 324 (in isoform 3) | Phosphorylation | - | 58.37 | 18669648 | |
| 325 | Acetylation | IEGDNENKLPREDGM EECCCCCCCCCCCCC | 54.40 | 26051181 | |
| 325 | Ubiquitination | IEGDNENKLPREDGM EECCCCCCCCCCCCC | 54.40 | 2190698 | |
| 325 (in isoform 1) | Ubiquitination | - | 54.40 | 21906983 | |
| 325 (in isoform 2) | Ubiquitination | - | 54.40 | 21906983 | |
| 353 | Phosphorylation | NVQVLLEYHIAYLKE CHHHHHHHHHHHHHH | 9.86 | 22817900 | |
| 357 | Phosphorylation | LLEYHIAYLKEVEQL HHHHHHHHHHHHHHH | 20.08 | 22817900 | |
| 360 | Methylation | YHIAYLKEVEQLRME HHHHHHHHHHHHHHH | 49.01 | 15782174 | |
| 365 | Methylation | LKEVEQLRMERLQID HHHHHHHHHHHHCHH | 25.30 | - | |
| 368 | Methylation | VEQLRMERLQIDEQL HHHHHHHHHCHHHHH | 23.66 | 15782174 | |
| 376 | Methylation | LQIDEQLRQIGSRSY HCHHHHHHHHCCCCC | 26.26 | - | |
| 386 | Methylation | GSRSYSGRGRGRRGP CCCCCCCCCCCCCCC | 26.20 | - | |
| 395 | Phosphorylation | RGRRGPNYTSGYGTN CCCCCCCCCCCCCCC | 12.86 | 25850435 | |
| 396 | Phosphorylation | GRRGPNYTSGYGTNS CCCCCCCCCCCCCCC | 23.47 | 23401153 | |
| 397 | Phosphorylation | RRGPNYTSGYGTNSE CCCCCCCCCCCCCCC | 21.47 | 23927012 | |
| 399 | Phosphorylation | GPNYTSGYGTNSELS CCCCCCCCCCCCCCC | 22.12 | 23927012 | |
| 401 | Phosphorylation | NYTSGYGTNSELSNP CCCCCCCCCCCCCCC | 27.39 | 23927012 | |
| 403 | Phosphorylation | TSGYGTNSELSNPSE CCCCCCCCCCCCCCC | 39.49 | 23927012 | |
| 406 | Phosphorylation | YGTNSELSNPSETES CCCCCCCCCCCCCHH | 42.52 | 23927012 | |
| 409 | Phosphorylation | NSELSNPSETESERK CCCCCCCCCCHHHHH | 62.49 | 23927012 | |
| 411 | Phosphorylation | ELSNPSETESERKDE CCCCCCCCHHHHHHH | 49.50 | 30278072 | |
| 413 | Phosphorylation | SNPSETESERKDELS CCCCCCHHHHHHHHC | 50.55 | 23927012 | |
| 416 | Ubiquitination | SETESERKDELSDWS CCCHHHHHHHHCHHH | 52.05 | - | |
| 420 | Phosphorylation | SERKDELSDWSLAGE HHHHHHHCHHHHCCC | 34.68 | 30266825 | |
| 423 | Phosphorylation | KDELSDWSLAGEDDR HHHHCHHHHCCCCCC | 17.21 | 30266825 | |
| 432 | Phosphorylation | AGEDDRDSRHQRDSR CCCCCCCCCHHHHCC | 32.34 | 30266825 | |
| 438 | Phosphorylation | DSRHQRDSRRRPGGR CCCHHHHCCCCCCCC | 29.85 | - | |
| 445 | Dimethylation | SRRRPGGRGRSVSGG CCCCCCCCCCCCCCC | 43.18 | - | |
| 445 | Methylation | SRRRPGGRGRSVSGG CCCCCCCCCCCCCCC | 43.18 | 15782174 | |
| 447 | Methylation | RRPGGRGRSVSGGRG CCCCCCCCCCCCCCC | 32.31 | - | |
| 448 | Phosphorylation | RPGGRGRSVSGGRGR CCCCCCCCCCCCCCC | 24.37 | 29496963 | |
| 450 | Phosphorylation | GGRGRSVSGGRGRGG CCCCCCCCCCCCCCC | 36.46 | 30177828 | |
| 453 | Dimethylation | GRSVSGGRGRGGPRG CCCCCCCCCCCCCCC | 34.85 | - | |
| 453 | Methylation | GRSVSGGRGRGGPRG CCCCCCCCCCCCCCC | 34.85 | 15782174 | |
| 455 | Dimethylation | SVSGGRGRGGPRGGK CCCCCCCCCCCCCCC | 45.60 | - | |
| 455 | Methylation | SVSGGRGRGGPRGGK CCCCCCCCCCCCCCC | 45.60 | - | |
| 459 | Dimethylation | GRGRGGPRGGKSSIS CCCCCCCCCCCCCHH | 70.53 | - | |
| 459 | Methylation | GRGRGGPRGGKSSIS CCCCCCCCCCCCCHH | 70.53 | - | |
| 462 | "N6,N6-dimethyllysine" | RGGPRGGKSSISSVL CCCCCCCCCCHHHHH | 43.80 | - | |
| 462 | Methylation | RGGPRGGKSSISSVL CCCCCCCCCCHHHHH | 43.80 | 23748837 | |
| 463 | O-linked_Glycosylation | GGPRGGKSSISSVLK CCCCCCCCCHHHHHC | 35.86 | 23301498 | |
| 463 | Phosphorylation | GGPRGGKSSISSVLK CCCCCCCCCHHHHHC | 35.86 | 21945579 | |
| 464 | Phosphorylation | GPRGGKSSISSVLKD CCCCCCCCHHHHHCC | 29.94 | 21945579 | |
| 466 | Phosphorylation | RGGKSSISSVLKDPD CCCCCCHHHHHCCCC | 19.15 | 21945579 | |
| 467 | Phosphorylation | GGKSSISSVLKDPDS CCCCCHHHHHCCCCC | 29.78 | 21945579 | |
| 470 | Acetylation | SSISSVLKDPDSNPY CCHHHHHCCCCCCCC | 66.13 | 26051181 | |
| 470 | Ubiquitination | SSISSVLKDPDSNPY CCHHHHHCCCCCCCC | 66.13 | - | |
| 474 | Phosphorylation | SVLKDPDSNPYSLLD HHHCCCCCCCCCCCC | 45.13 | 21945579 | |
| 477 | Phosphorylation | KDPDSNPYSLLDNTE CCCCCCCCCCCCCCC | 19.05 | 21945579 | |
| 478 | Phosphorylation | DPDSNPYSLLDNTES CCCCCCCCCCCCCCC | 24.58 | 21945579 | |
| 483 | Phosphorylation | PYSLLDNTESDQTAD CCCCCCCCCCCCCCC | 36.21 | 21945579 | |
| 485 | Phosphorylation | SLLDNTESDQTADTD CCCCCCCCCCCCCCC | 32.74 | 21945579 | |
| 488 | Phosphorylation | DNTESDQTADTDASE CCCCCCCCCCCCHHH | 31.34 | 21945579 | |
| 491 | Phosphorylation | ESDQTADTDASESHH CCCCCCCCCHHHCHH | 30.88 | 21945579 | |
| 494 | Phosphorylation | QTADTDASESHHSTN CCCCCCHHHCHHHHH | 42.30 | 21945579 | |
| 496 | Phosphorylation | ADTDASESHHSTNRR CCCCHHHCHHHHHHH | 24.81 | 21945579 | |
| 499 | Phosphorylation | DASESHHSTNRRRRS CHHHCHHHHHHHHHH | 23.19 | 21945579 | |
| 500 | Phosphorylation | ASESHHSTNRRRRSR HHHCHHHHHHHHHHH | 28.52 | 21945579 | |
| 506 | Phosphorylation | STNRRRRSRRRRTDE HHHHHHHHHHCCCCC | 28.47 | - | |
| 511 | Phosphorylation | RRSRRRRTDEDAVLM HHHHHCCCCCCCEEC | 41.76 | 28985074 | |
| 511 (in isoform 2) | Phosphorylation | - | 41.76 | 27273156 | |
| 522 | Phosphorylation | AVLMDGMTESDTASV CEECCCCCHHHCCCC | 37.56 | - | |
| 522 (in isoform 2) | Phosphorylation | - | 37.56 | 30266825 | |
| 524 | Phosphorylation | LMDGMTESDTASVNE ECCCCCHHHCCCCCC | 30.97 | 28985074 | |
| 524 (in isoform 2) | Phosphorylation | - | 30.97 | 30266825 | |
| 526 | Phosphorylation | DGMTESDTASVNENG CCCCHHHCCCCCCCC | 30.06 | 28985074 | |
| 526 (in isoform 2) | Phosphorylation | - | 30.06 | 30266825 | |
| 528 | Phosphorylation | MTESDTASVNENGLV CCHHHCCCCCCCCCE | 27.80 | 19690332 | |
| 528 (in isoform 2) | Phosphorylation | - | 27.80 | 30266825 | |
| 540 | Phosphorylation | GLVTVADYISRAESQ CCEEHHHHHHHHHHH | 7.34 | - | |
| 542 | Phosphorylation | VTVADYISRAESQSR EEHHHHHHHHHHHHH | 21.14 | 22496350 | |
| 546 | Phosphorylation | DYISRAESQSRQRNL HHHHHHHHHHHHHCC | 32.25 | 26853621 | |
| 557 | Phosphorylation | QRNLPRETLAKNKKE HHCCCHHHHHHCHHH | 33.04 | 28555341 | |
| 565 | Sulfoxidation | LAKNKKEMAKDVIEE HHHCHHHHHHHHHHH | 8.46 | 21406390 | |
| 567 | Acetylation | KNKKEMAKDVIEEHG HCHHHHHHHHHHHHC | 51.74 | 25953088 | |
| 576 | Phosphorylation | VIEEHGPSEKAINGP HHHHHCCCHHHCCCC | 57.21 | 26074081 | |
| 578 | Acetylation | EEHGPSEKAINGPTS HHHCCCHHHCCCCCC | 59.93 | 23236377 | |
| 584 | Phosphorylation | EKAINGPTSASGDDI HHHCCCCCCCCCCCH | 38.02 | 30266825 | |
| 585 | Phosphorylation | KAINGPTSASGDDIS HHCCCCCCCCCCCHH | 24.46 | 30266825 | |
| 587 | Phosphorylation | INGPTSASGDDISKL CCCCCCCCCCCHHHH | 42.39 | 30266825 | |
| 592 | Phosphorylation | SASGDDISKLQRTPG CCCCCCHHHHCCCCC | 34.02 | 30266825 | |
| 593 | Acetylation | ASGDDISKLQRTPGE CCCCCHHHHCCCCCH | 49.31 | 26051181 | |
| 597 | Phosphorylation | DISKLQRTPGEEKIN CHHHHCCCCCHHHHH | 23.76 | 25159151 | |
| 605 | Phosphorylation | PGEEKINTLKEENTQ CCHHHHHHHCHHCHH | 42.55 | 24732914 | |
| 607 | Acetylation | EEKINTLKEENTQEA HHHHHHHCHHCHHHH | 62.03 | 26051181 | |
| 611 | Phosphorylation | NTLKEENTQEAAVLN HHHCHHCHHHHHHHC | 30.94 | 28112733 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 445 | R | Methylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FXR1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FMR1_HUMAN | FMR1 | physical | 7489725 | |
| CYFP2_HUMAN | CYFIP2 | physical | 11438699 | |
| DPYL1_HUMAN | CRMP1 | physical | 16169070 | |
| GBP2_HUMAN | GBP2 | physical | 16169070 | |
| CE126_HUMAN | KIAA1377 | physical | 16169070 | |
| ERG28_HUMAN | C14orf1 | physical | 16169070 | |
| LC7L2_HUMAN | LUC7L2 | physical | 16169070 | |
| LRIF1_HUMAN | LRIF1 | physical | 16169070 | |
| FXR2_HUMAN | FXR2 | physical | 8668200 | |
| FXR2_HUMAN | FXR2 | physical | 7489725 | |
| FXR1_HUMAN | FXR1 | physical | 7489725 | |
| CAPR1_HUMAN | CAPRIN1 | physical | 24778252 | |
| FMR1_HUMAN | FMR1 | physical | 24778252 | |
| FXR2_HUMAN | FXR2 | physical | 24778252 | |
| LRWD1_HUMAN | LRWD1 | physical | 24778252 | |
| ORC2_HUMAN | ORC2 | physical | 24778252 | |
| RANB9_HUMAN | RANBP9 | physical | 24778252 | |
| TDRD3_HUMAN | TDRD3 | physical | 24778252 | |
| TOP3B_HUMAN | TOP3B | physical | 24778252 | |
| UBAP2_HUMAN | UBAP2 | physical | 24778252 | |
| FBX4_HUMAN | FBXO4 | physical | 29142209 | |
| SKP1_HUMAN | SKP1 | physical | 29142209 | |
| CUL1_HUMAN | CUL1 | physical | 29142209 | |
| RBX1_HUMAN | RBX1 | physical | 29142209 | |
| GSK3B_HUMAN | GSK3B | physical | 29142209 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Methylation | |
| Reference | PubMed |
| "Identifying and quantifying in vivo methylation sites by heavy methylSILAC."; Ong S.E., Mittler G., Mann M.; Nat. Methods 1:119-126(2004). Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-445, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406; SER-409; SER-524;SER-528 AND SER-587, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406 AND SER-409, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-477, AND MASSSPECTROMETRY. | |